In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
Novo Nordisk’s GLP-1 Pill Hits US Pharmacies as Wegovy Shows Promise Against Alcohol Addiction
Novo Nordisk enters a pivotal week: Wegovy cuts heavy drinking days by 70% in a new study, oral…
Oral Ozempic Hits Pharmacies as Earnings Test Investor Patience
Novo Nordisk launches oral Ozempic in the US amid Q1 earnings decline, Eli Lilly competition, and patent pressures.…
Novo Nordisk Ups the Ante with Wegovy HD Rollout
In a significant development for the weight-loss drug market, Novo Nordisk has introduced a higher-dose version of…
Century-old Tallinn pharmacy keeps legacy of Estonia’s first woman pharmacist | News
Suur-Pärnu Pharmacy in Tallinn was founded by Estonia’s first woman pharmacist, Olympiada Kann. A century later, its current…
Hims & Hers launch of compounded $49 Wegovy pill pummeled Novo Nordisk’s shares
Last Updated: Feb. 5, 2026 at 4:08 p.m. ETFirst Published: Feb. 5, 2026 at 10:56 a.m. ET Hims & Hers…